Allweiss L. Strong intrahepatic decline of hepatitis D virus RNA and antigen after 24 weeks of treatment with Myrcludex B in combination with Tenofovir in chronic HBV/HDV infected patients: Interim results from a multicenter, open-label phase 2b clinical trial. PS-162.
Vroege behandeling van milde tot matige COVID-19 met sotrovimab reduceert risico op progressie
apr 2022 | Pneumonie, Virale infecties